Strategies for integrating personalized medicine into healthcare practice

Personalized Medicine
Daryl E PritchardHoward L McLeod

Abstract

Research and innovation in personalized medicine are surging, however, its adoption into clinical practice is comparatively slow. We identify common challenges to the clinical adoption of personalized medicine and provide strategies for addressing these challenges. Our team developed a list of common challenges through a series of group discussions, surveys and interviews, and convened a national summit to discuss solutions for overcoming these challenges. We used a framework approach for thematic analysis. We categorized challenges into five areas of need: education and awareness; patient empowerment; value recognition; infrastructure and information management; and ensuring access to care. We then developed strategies to address these challenges. In order for healthcare to transition into personalized medicine, it is necessary for stakeholders to build momentum by implementing a progression of strategies.

References

Feb 19, 2011·Science·James P EvansTimothy Caulfield
Apr 8, 2011·Health Affairs·Floyd J FowlerKaren R Sepucha
Jan 12, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Teri A ManolioGeoffrey S Ginsburg
Jul 18, 2014·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Angela R BradburySusan Domchek
May 28, 2015·The New England Journal of Medicine·Heidi L RehmUNKNOWN ClinGen
Jul 17, 2015·Clinical Trials : Journal of the Society for Clinical Trials·Beverly H LorellAnnemarie Forrest
Nov 20, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Nanibaa' A GarrisonEllen W Clayton
Dec 5, 2015·Expert Review of Molecular Diagnostics·Akihiro NishiShuji Ogino

❮ Previous
Next ❯

Citations

Oct 25, 2017·Pharmacogenomics·Kathi L HuddlestonSusanne B Haga
May 2, 2018·Personalized Medicine·Adam Tarring
Dec 1, 2017·Current Opinion in Allergy and Clinical Immunology·Giorgio W CanonicaEnrico Heffler
Apr 27, 2019·Personalized Medicine·Richard TaRodolfo Coloso
Sep 14, 2017·Frontiers in Public Health·Margo W BergmanHeather Honoré Goltz
Nov 7, 2018·Journal of Innovation in Health Informatics·Scott McLachlanNorman Fenton
Sep 18, 2020·AJOB Empirical Bioethics·Julie A BeansPaul Spicer
Aug 14, 2020·Regional Anesthesia and Pain Medicine·Brigitte BrouwerNelleke de Meij
May 8, 2018·Health Affairs·Geoffrey S Ginsburg, Kathryn A Phillips
Feb 13, 2019·British Medical Bulletin·S G AttarM W Beresford
Sep 5, 2019·Archives of Endocrinology and Metabolism·Waldemar VolanskiGeraldo Picheth
Jan 31, 2020·Yonsei Medical Journal·Ha Na ChoEun Sook Lee
Oct 28, 2018·BMC Medical Genomics·Huey Yi ChongNathorn Chaiyakunapruk
Mar 2, 2018·International Journal of Audiology·Vishakha W Rawool, Chelsea Campbell
Nov 2, 2020·Life Sciences, Society and Policy·M Walid QoronflehSaid Ismail
Mar 7, 2021·Journal of Personalized Medicine·Deborah TraversiStefania Boccia
Mar 31, 2021·Journal of Community Genetics·Eka KvaratskheliaElene Abzianidze
Apr 7, 2021·Drug Metabolism Reviews·Laura E RussellVolker M Lauschke
Apr 17, 2021·International Immunopharmacology·Torsak TippairoteGeir Bjørklund
Jul 3, 2021·Journal of Personalized Medicine·Jolyane Blouin-BougieJacques Simard
Jul 27, 2021·Current Therapeutic Research, Clinical and Experimental·Davide GrisafiFrancesco Scaglione
Aug 1, 2021·Molecular Diagnosis & Therapy·Jesús García-FoncillasMaría Vanessa Pérez Gómez

❮ Previous
Next ❯

Software Mentioned

NextGxDx
PMC

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.